Search Results for "Cvs Minute Clinic Shingles Vaccine"

07:13 EST 21st November 2017 | BioPortfolio

Matching Channels


Varicella zoster virus (VZV) is one of eight herpes viruses known to infect humans (and other vertebrates). Varicella-zoster virus is known by many names, including: chickenpox virus, varicella viru...

HPV vaccine

Rotavirus Vaccine GSK

Smallpox Vaccine MVA

Poliovirus Vaccine OPV

Matching News

New Shingles Vaccine, Shingrix, Approved by FDA

A new, more effective shingles vaccine has been approved by the U.S. Food and Drug Administration. The new vaccine from GlaxoSmithKline will be the second shingles vaccine available in the U.S. market...

STAT Plus: GSK’s new shingles vaccine may win nod over Merck’s Zostavax

October is shaping up to be a momentous month for GlaxoSmithKline’s new shingles vaccine, Shingrix. The Food and Drug Administration may approve the vaccine for the U.S. market by the…

Correction: FDA-Shingles Vaccine story

In a story Oct. 20 about U.S. approval of GlaxoSmithKline's shingles vaccine, The Associated Press reported erroneously that the drugmaker is testing its new vaccine against an older one sold by M...

CDC committee favours GSK’s shingles vaccine

The US Centre for Disease Control Prevention's Advisory Committee on Immunisation Practices (ACIP) has given its backing to GlaxoSmithKline’s newly approved shingles vaccine Shingrix over Merck ...

There's a New Shingles Vaccine, Shingrix, -- Is It for You?

THURSDAY, Oct. 26, 2017 -- On the heels of approval of a better vaccine for the painful condition shingles, adults over 50 should plan to roll up their sleeves -- again. The new vaccine, Shingrix, wil...

GSK's shingles vaccine scores US approval

GlaxoSmithKline has announced that its shingles vaccine Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been awarded FDA approval for the prevention of the disease in patients aged 50 or older. ...

CDC recommends new vaccine for shingles

Last month a U.S. Food and Drug Administration (FDA) advisory panel had voted 11 to 0 approving a shingles vaccine for its use in adults aged 50 and over. The panel unanimously accepted the safety and...

FDA approves better vaccine against painful shingles virus

This image provided by GlaxoSmithKline shows the company's Shingrix vaccine. On Friday, Oct. 20, 2017, the Food and Drug Administration approved the vaccine to prevent painful shingles in people a...

Matching PubMed Articles

The effectiveness of shingles vaccine among Albertans aged 50 years or older: A retrospective cohort study.

We assessed the effectiveness of shingles vaccine in preventing incident shingles among Alberta residents aged 50 years or older over the period 2009 - 2015, using administrative health data.

A critical appraisal of 'Shingrix', a novel Herpes Zoster Subunit (HZ/Su or GSK1437173A) vaccine for Varicella Zoster Virus.

HZ/Su, branded as 'Shingrix', is one of the newest vaccines to be submitted for multi-national regulatory approval. It is targeted to prevent shingles, predominantly affecting the elderly, but a globa...

Bivalent vaccine effectiveness against type-specific HPV positivity: evidence for cross-protection against oncogenic types among Dutch STI clinic visitors.

Observational post-marketing studies are important to assess vaccine effectiveness (VE). We estimated VE from the bivalent human papillomavirus (HPV) vaccine against HPV positivity of vaccine and non-...

Preventing herpes zoster through vaccination: New developments.

Herpes zoster (HZ) affects 1 million Americans every year. The disease burden is higher in immunocompromised patients. The live-attenuated HZ vaccine is effective in preventing HZ and postherpetic neu...

Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.

Recent manufacturing problems resulted in a shortage of the only U.S.-licensed yellow fever vaccine. This shortage is expected to lead to a complete depletion of yellow fever vaccine available for the...

Search Whole site using Google

Quick Search
Advertisement Advertisement